8-K
filed April 24, 2024, 7:59 PM ET
ticker ABEO
CIK 0000318306
other
confidence high
sentiment neutral
materiality 0.45
Abeona shareholders approve equity plan increase to 3.2M shares; re-elect two directors
ABEONA THERAPEUTICS INC.
- A&R 2023 Equity Incentive Plan approved, increasing shares reserved from 1.7M to 3.2M (1.5M new shares).
- Leila Alland and Vishwas Seshadri re-elected as Class 2 directors with overwhelming support.
- Advisory vote on named executive officer compensation approved: 9,529,727 for, 402,844 against.
- Ratification of Deloitte & Touche as independent auditor for FY2024 approved: 14,720,159 for.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ABEONA THERAPEUTICS INC. shareholders approved Election of Directors at the 2024-04-24 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-04-24
Exact text from the filing
Leila Alland and Vishwas Seshadri were elected to serve as Class 2 directors of the Company until the 2027 annual meeting of stockholders and until their successors are elected and qualified. The results of the election of directors are as follows: Nominee Votes Non-Votes Leila Alland 8,985,852 958,122 12,938 5,093,839 Vishwas Seshadri 9,922,210 21,390 13,312 5,093,839
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ABEONA THERAPEUTICS INC. shareholders approved Ratification of the Appointment of Deloitte & Touche LLP as our Independent Registered Public Accounting Firm at the 2024-04-24 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-04-24
Exact text from the filing
A proposal to ratify the appointment of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2024 was approved by the following votes: Votes Non-Votes 14,720,159 136,942 193,650 —
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ABEONA THERAPEUTICS INC. shareholders approved Approval of an Increase in the Number of Shares Reserved for Issuance Under the A&R Plan at the 2024-04-24 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2024-04-24
Exact text from the filing
A proposal to approve an increase in the number of shares reserved for issuance under the A&R Plan from 1,700,000 to 3,200,000 shares was approved based on the following votes: Votes Non-Votes 9,358,912 570,314 27,686 5,093,839
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
ABEONA THERAPEUTICS INC. shareholders approved Advisory Vote on Compensation of Named Executive Officers at the 2024-04-24 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-04-24
Exact text from the filing
An advisory vote to approve the compensation of the Company’s named executive officers was approved by the following votes: Votes Non-Votes 9,529,727 402,844 24,341 5,093,839
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.